These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 19963078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M, Fuentes P, Gilman RH, Gutiérrez AH, Kirwan D, Sheen P.
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [Abstract] [Full Text] [Related]

  • 3. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F, Telles MA, Ribeiro MO, Cafrune PI, Rossetti ML, Zaha A.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [Abstract] [Full Text] [Related]

  • 4. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
    Zhang H, Bi LJ, Li CY, Sun ZG, Deng JY, Zhang XE.
    J Int Med Res; 2009 Jan; 37(5):1430-5. PubMed ID: 19930847
    [Abstract] [Full Text] [Related]

  • 5. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
    Yoon JH, Nam JS, Kim KJ, Ro YT.
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2821-8. PubMed ID: 25034468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M, Fonteyne PA, Realini L, Rossau R, Jannes G, Mijs W, De Smet KA, Portaels F, Van den Eeckhout E.
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P, Ferrer P, Gilman RH, López-Llano J, Fuentes P, Valencia E, Zimic MJ.
    Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
    [Abstract] [Full Text] [Related]

  • 12. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT.
    BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001
    [Abstract] [Full Text] [Related]

  • 13. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
    Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V.
    Antimicrob Agents Chemother; 1999 Jul 06; 43(7):1761-3. PubMed ID: 10390238
    [Abstract] [Full Text] [Related]

  • 14. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y.
    Antimicrob Agents Chemother; 2000 Mar 06; 44(3):528-32. PubMed ID: 10681313
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C, Yamane N, Yogesh B, Ano H, Takashima T.
    Diagn Microbiol Infect Dis; 2004 Feb 06; 48(2):111-6. PubMed ID: 14972380
    [Abstract] [Full Text] [Related]

  • 17. Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.
    Rueda D, Bernard C, Gandy L, Capton E, Boudjelloul R, Brossier F, Veziris N, Zimic M, Sougakoff W.
    Int J Mycobacteriol; 2018 Feb 06; 7(1):16-25. PubMed ID: 29516881
    [Abstract] [Full Text] [Related]

  • 18. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.
    Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM.
    Antimicrob Agents Chemother; 1997 Mar 06; 41(3):636-40. PubMed ID: 9056006
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.